Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
小儿止咳糖浆 (Pediatric Cough Syrup) is an approved combination pharmaceutical product developed by Hainan Huluwa Pharmaceutical Group for the symptomatic relief of cough associated with pediatric colds. The formulation integrates traditional herbal extracts with conventional chemical expectorants. It contains licorice extract and platycodon extract, which function as herbal expectorants and soothing agents, alongside ammonium chloride, a small molecule expectorant that increases respiratory tract fluid secretion to facilitate phlegm removal. Orange peel tincture is also included as an adjunct. The product is administered orally as a syrup and is commercially available in China in both bottle and soft bag packaging formats.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on 小儿止咳糖浆.